Company profile
Mirabilis Therapeutics company profile
Mirabilis Therapeutics develops the next generation microRNA medicines in the areas of cardiovascular and metabolic disorders. Their mission is to become Europe’s number one microRNA developing and commercializing company, developing high medical need drugs for and in close collaboration with doctors and patients.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Maastricht, Limburg, The Netherlands
- Postal code
- 6229 EV
- Country code
- NL
- Continent
- Europe